肝血管瘤是肝脏最常见的良性肿瘤，近年来检出率逐年增高。随着介入和微创等技术的发展，目前针对肝血管瘤的临床治疗展现出多元化、个体化、综合化和微创化的趋势。然而由于一些医师对肝血管瘤的发展及治疗原则认识不足，也随之带来一系列诸如治疗指征过宽、风险评估不足、治疗方法选择不当等问题。因此，如何规范肝血管瘤的治疗，使病人达到最佳的风险效益比，已经成为当前迫切需要解决的重要问题。

Standardized treatment and problems worthy of attention for  hemangioma of liver        BAI Xue-li, CHEN Wei, LIANG Ting-bo. Department of Hepatobiliary ＆ Pancreas Surgery，Liver Transplantation Center，Second Affiliated Hospital，School of Medicine，Zhejiang University，Hangzhou 31009，China
Corresponding author：LIANG Ting-bo，E-mail：liangtingbo@zju.edu.cn
Abstract    Hepatic hemangioma is the most common benign tumor of liver. The detection rate is rising year by year. Different clinical treatment methods of liver hemangioma have existed, which include liver resection，enucleation，radiofrequence ablation，transarterial embolism and so on. The management tendency of diversification, individuation, integration and minimally invasion has existed gradually. However，because of lack of knowledge about the pathogenesis and management principle in some surgeons, some problems have existed such as excessive indication, insufficient risk evaluation, inappropriate management, etc. How to give a standard management of hepatic hemangioma in order to get the best risk benefit ratio has become the urgent problem at present.